"academist" and Sysmex R&D Center Europe to Begin Collaboratin... - 17 December 2021 17:00

TOKYO, Dec. 17, 2021 /Kyodo JBN-AsiaNet/ -- academist, Inc., which operates Japan's first academic crowdfunding platform ( https://academist-cf.com/?lang=en ), and Sysmex R&D Center Europe GmbH (hereinafter "Sysmex R&D Center Europe," https://www.sysmex-rdce.com/ ), which is engaged in supp...

  Debiopharm Further Explores the Potential of its Potent, Highl... - 16 December 2021 19:00

LAUSANNE, Switzerland, December 16, 2021 /PRNewswire-AsiaNet/ - - Dose escalation, monotherapy trial launched to access the safety and preliminary anti-tumor activity of Debio 0123 in the treatment of advanced solid tumors Debiopharm (www.debiopharm.com), a Swiss biopharmaceutical company, announced...

  French Neurosurgeon and Physicist Dr. Alim Louis Benabid, Reci... - 16 December 2021 18:00

TOKYO, Dec. 16, 2021 /Kyodo JBN-AsiaNet/-- - Commended for His Pioneering Research into Deep Brain Stimulation (DBS) (*) and Contribution to Treating Involuntary Movements Caused by Parkinson's Disease - The Honda Foundation, based in Tokyo, is pleased to announce that the 42nd Honda Pr...

  PHASE 3 TRIAL OF SHR8058 EYE DROPS (PERFLUOROHEXYLOCTANE) COND... - 16 December 2021 18:00

HEIDELBERG, Germany, and CAMBRIDGE, Mass., Dec. 16, 2021 /PRNewswire-AsiaNet/-- Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on the unique EyeSol(R) water-free technology, today provided a development update on the phase 3 trial of SHR8058 eye drops (perfluorohexyloctane)...

  Novavax Announces Submission of New Drug Application in Japan ... - 16 December 2021 16:07

GAITHERSBURG, Md., Dec. 16, 2021 /PRNewswire-AsiaNet/-- -- Takeda submits application for TAK-019/NVX-CoV2373, the first protein-based COVID-19 vaccine candidate for NDA, to Japan's Ministry of Health, Labour and Welfare (MHLW) -- Interim data from Phase 1/2 trial in Japan demonstrate robust immune ...

  Menarini Silicon Biosystems announces new DEPArray(TM) PLUS ap... - 16 December 2021 08:37

BOLOGNA, Italy and HUNTINGDON VALLEY, Pa., Dec. 16, 2021 /PRNewswire-AsiaNet/ -- Tissue biopsies with tumor cell contents that are too low for conventional testing methods can now be rescued due to the ability of MSB's DEPArray technology to successfully recover low numbers of tumor cells from these difficult samples. The new...

  FDA Breakthrough Devices Designation Application to Fast-Track... - 16 December 2021 00:01

SYDNEY, Australia, Dec. 15, 2021 /Medianet International-AsiaNet/ -- Life Science Biosensor Diagnostics Pty Ltd (LSBD), a life sciences and medical technology company and subsidiary of The iQ Group Global, announced it has filed an application with the U.S Food and Drug Administration (FDA) for Breakthrough Devices...

  BenevolentAI achieves second major collaboration milestone wit... - 15 December 2021 19:00

LONDON, Dec. 15, 2021 /PRNewswire-AsiaNet/ -- - Novel target for idiopathic pulmonary fibrosis was discovered using BenevolentAI's AI-drug discovery platform and experimentally validated by AstraZeneca - Announcement represents the second collaboration milestone following the addition of a...

  GenScript Receives "COVID Management Initiative of the Year" i... - 15 December 2021 18:24

SINGAPORE, Dec. 15, 2021 /PRNewswire-AsiaNet/ -- GenScript receives the award on COVID Management Initiative of the Year, Biotechnology industry in the Singapore Business Review (SBR) Management Excellence Award 2021. GenScript showed strong commitment and support to global COVID-19 management i...

  Argon Medical Devices, Inc. Acquires Matrex Mold and Tool, Inc. - 15 December 2021 05:11

FRISCO, Texas, Dec. 15, 2021 /PRNewswire-AsiaNet/ -- Argon Medical Devices, Inc., a leading manufacturer of medical devices for interventional procedures, announced the acquisition of Wisconsin-based Matrex Mold and Tool, Inc., a custom mold manufacturer for plastic injection molding. Matrex produce...